DE69940051D1 - Wasserlösliche trockene zusammensetzungen - Google Patents

Wasserlösliche trockene zusammensetzungen

Info

Publication number
DE69940051D1
DE69940051D1 DE69940051T DE69940051T DE69940051D1 DE 69940051 D1 DE69940051 D1 DE 69940051D1 DE 69940051 T DE69940051 T DE 69940051T DE 69940051 T DE69940051 T DE 69940051T DE 69940051 D1 DE69940051 D1 DE 69940051D1
Authority
DE
Germany
Prior art keywords
dry compositions
amino acids
hydrophobic amino
defoaming agents
soluble dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940051T
Other languages
English (en)
Inventor
Chikamasa Yamashita
Masaaki Odomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69940051D1 publication Critical patent/DE69940051D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DE69940051T 1998-06-26 1999-06-24 Wasserlösliche trockene zusammensetzungen Expired - Lifetime DE69940051D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18079698 1998-06-26
PCT/JP1999/003369 WO2000000221A1 (fr) 1998-06-26 1999-06-24 Compositions seches solubles dans l'eau

Publications (1)

Publication Number Publication Date
DE69940051D1 true DE69940051D1 (de) 2009-01-22

Family

ID=16089500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940051T Expired - Lifetime DE69940051D1 (de) 1998-06-26 1999-06-24 Wasserlösliche trockene zusammensetzungen

Country Status (15)

Country Link
US (2) US6337067B1 (de)
EP (1) EP1018345B1 (de)
JP (1) JP4332694B2 (de)
KR (1) KR100652943B1 (de)
CN (1) CN100341575C (de)
AT (1) ATE416790T1 (de)
AU (1) AU760940B2 (de)
CA (1) CA2301889C (de)
DE (1) DE69940051D1 (de)
DK (1) DK1018345T3 (de)
ES (1) ES2317695T3 (de)
HK (1) HK1028738A1 (de)
ID (1) ID24279A (de)
PT (1) PT1018345E (de)
WO (1) WO2000000221A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758794B2 (en) 2001-10-29 2010-07-20 Princeton University Method of making an article comprising nanoscale patterns with reduced edge roughness
EP1254944B1 (de) * 1999-12-24 2007-03-28 Otsuka Pharmaceutical Co., Ltd. Hydrophobe aminosäuren enthaltende trockene zusammensetzung
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP4610154B2 (ja) * 2002-05-30 2011-01-12 大塚製薬株式会社 注射用製剤
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
US20100217664A1 (en) * 2007-09-07 2010-08-26 Ryan Steelberg Engine, system and method for enhancing the value of advertisements
EP2236520A1 (de) * 2009-03-31 2010-10-06 Leukocare Ag Stabilisierungszusammensetzung für immobilisierte Biomoleküle
PL2533791T3 (pl) * 2009-12-21 2017-10-31 Glanbia Nutritionals Ireland Ltd Kompozycja leucyny/peptydu i sposób jej sporządzania
JP6431372B2 (ja) 2011-10-25 2018-11-28 プロシーナ バイオサイエンシーズ リミテッド 抗体製剤および方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168008A3 (de) 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stabile Gamma-Interferonzusammensetzung
DE4242863A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
CN1045390C (zh) * 1994-06-16 1999-10-06 谭灿文 复合氨基酸冲剂
TW403653B (en) * 1995-12-25 2000-09-01 Otsuka Pharma Co Ltd Dry compositions

Also Published As

Publication number Publication date
WO2000000221A9 (fr) 2000-07-27
AU760940B2 (en) 2003-05-22
ES2317695T3 (es) 2009-04-16
US20010049361A1 (en) 2001-12-06
DK1018345T3 (da) 2009-03-23
ID24279A (id) 2000-07-13
EP1018345A1 (de) 2000-07-12
EP1018345A4 (de) 2005-01-26
CA2301889C (en) 2008-02-19
PT1018345E (pt) 2009-01-23
AU4392899A (en) 2000-01-17
KR20010023269A (ko) 2001-03-26
CN100341575C (zh) 2007-10-10
CA2301889A1 (en) 2000-01-06
JP4332694B2 (ja) 2009-09-16
ATE416790T1 (de) 2008-12-15
HK1028738A1 (en) 2001-03-02
WO2000000221A1 (fr) 2000-01-06
US6479048B2 (en) 2002-11-12
US6337067B1 (en) 2002-01-08
EP1018345B1 (de) 2008-12-10
CN1272795A (zh) 2000-11-08
KR100652943B1 (ko) 2006-12-01

Similar Documents

Publication Publication Date Title
AU2001275305A1 (en) Rinse agent composition and method for rinsing a substrate surface
AU4549989A (en) Aqueous ophthalmic solutions and method for preserving same
CA2198004A1 (en) Rinse aid for plasticware
CA2209048A1 (en) Aqueous curable alkoxy silane/alkoxy silylated polymer compositions with extended shelf life
DE60011403D1 (de) Bioadhesive zusammensetzungen
ATE93678T1 (de) Mikrobiozide jodzusammensetzung.
EP0914814A4 (de) Emulsionzusammensetzung
DE69940051D1 (de) Wasserlösliche trockene zusammensetzungen
CA2036283A1 (en) Effervescent composition, its production and use
GR3003622T3 (de)
FI921304A0 (fi) Besprutningsbara jordbruks- kompositioner.
ES2124063T3 (es) Composiciones de microemulsiones de compuestos de 3-isotiazolonas.
CA2178163A1 (en) Water soluble granular compositions comprising an imidazolinone herbicide and a base
WO2003048342A3 (en) Liquid yeast compositions
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
NO943373L (no) Psyliumholdig sammensatt blandingsdrikk
CA2331076A1 (en) Stable carbanilide composition
TH20636B (th) สารต้านเชื้อราแบบผสม
BR9106740A (pt) Formulacao diluidora proporcionando propriedades de sustentacao a produtos agricolas
RU98109064A (ru) Глазные пленки
Botting More than making the grade
DK0553647T3 (da) Vandige polymerisatsammensætninger
AU5766790A (en) Liquid polymer composition, and method of use
TW371629B (en) Solubilized cosmetic composition containing alkyl modified carboxyvinyl polymer and hydroxyalkylated cyclodextrin
TH9141EX (th) ส่วนประกอบสำหรับรักษาเส้นผม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition